Zithromax-SR 2g, Special Investigation For Skin And Soft Tissue Infection, Sexually-Transmitted Infection, And Infection Of The Oral (Regulatory Post Marketing Commitment Plan).

Trial Profile

Zithromax-SR 2g, Special Investigation For Skin And Soft Tissue Infection, Sexually-Transmitted Infection, And Infection Of The Oral (Regulatory Post Marketing Commitment Plan).

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Apr 2012

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Bacterial infections; Oral infections; Sexually transmitted infections; Skin infections; Soft tissue infections
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 24 Feb 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 24 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Nov 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top